Human remyelination promoting antibody inhibits apoptotic signaling and differentiation through Lyn kinase in primary rat oligodendrocytes

GLIA

Volumn 58, Issue 15, 2010, Pages 1782-1793

  Watzlawik, J ^a,b   Holicky, E ^b   Edberg, D D ^a   Marks, D L ^b   Warrington, A E ^a   Wright, B R ^a   Pagano, R E ^a,b   Rodriguez, M ^a  

^a Mayo Clinic   (United States)

^b MAYO GRADUATE SCHOOL   (United States)

Author keywords

Demyelination; Fibronectin; Multiple sclerosis; Src family kinase

Indexed keywords

2,3 DIHYDRO 2 OXO 3 (4,5,6,7 TETRAHYDRO 1H INDOL 2 YLMETHYLENE) 1H INDOLE 5 SULFONIC ACID DIMETHYLAMIDE; 4 AMINO 7 TERT BUTYL 5 (4 CHLOROPHENYL)PYRAZOLO[3,4 D]PYRIMIDINE; BETA3 INTEGRIN; CASPASE 3; CASPASE 9; IMMUNOGLOBULIN M ANTIBODY; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN KINASE LYN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL PROTECTION; CELL SURVIVAL; DOWNSTREAM PROCESSING; DRUG MECHANISM; ENZYME ACTIVATION; IMMUNOPRECIPITATION; NONHUMAN; OLIGODENDROGLIA; ONCOGENE SRC; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; RAT; REMYELINIZATION; SIGNAL TRANSDUCTION; UPREGULATION; WESTERN BLOTTING;

ANIMALS; ANIMALS, NEWBORN; APOPTOSIS; BRAIN; CASPASE 3; CELL DIFFERENTIATION; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; IMMUNOGLOBULIN M; IMMUNOPRECIPITATION; INDOLES; INTEGRIN BETA3; OLIGODENDROGLIA; PHOSPHORYLATION; PREGNANCY; PYRIMIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION; SRC-FAMILY KINASES; SULFONAMIDES;

EID: 78649338732     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.21048     Document Type: Article

References (45)

1. Asakura K, Miller DJ, Murray K, Bansal R, Pfeiffer SE, Rodriguez M. 1996a. Monoclonal autoantibody SCH94.03, which promotes central nervous system remyelination, recognizes an antigen on the surface of oligodendrocytes. J Neurosci Res 43:273-281.
2. Asakura K, Pogulis RJ, Pease LR, Rodriguez M. 1996b. A monoclonal autoantibody which promotes central nervous system remyelination is highly polyreactive to multiple known and novel antigens. J Neuro-immunol 65:11-19.
3. Bain J, McLauchlan H, Elliott M, Cohen P. 2003. The specificities of protein kinase inhibitors: An update. Biochem J 371(Part 1):199-204
4. Bain J, Plater L, Elliott M, Shpiro N, Hastie CJ, McLauchlan H, Klevernic I, Arthur JS, Alessi DR, Cohen P. 2007. The selectivity of protein kinase inhibitors: A further update. Biochem J 408:297-315.
5. Baron W, Colognato H, ffrench-Constant C. 2005. Integrin-growth factor interactions as regulators of oligodendroglial development and function. Glia 49:467-479.
6. Baron W, Decker L, Colognato H, ffrench-Constant C. 2003. Regulation of integrin growth factor interactions in oligodendrocytes by lipid raft microdomains. Curr Biol 13:151-155
7. Baron W, Shattil SJ, ffrench-Constant C. 2002. The oligodendrocyte precursor mitogen PDGF stimulates proliferation by activation of alpha(v)beta3 integrins. Embo J 21:1957-1966.
8. Benninger Y, Colognato H, Thurnherr T, Franklin RJ, Leone DP, Atanasoski S, Nave KA, Ffrench-Constant C, Suter U, Relvas JB. 2006. Beta1-integrin signaling mediates premyelinating oligodendrocyte survival but is not required for CNS myelination and remyelination. J Neurosci 26:7665-7673.
9. Blake RA, Broome MA, Liu X, Wu J, Gishizky M, Sun L, Courtneidge SA. 2000. SU6656, a selective src family kinase inhibitor, used to probe growth factor signaling. Mol Cell Biol 20:9018-9027.
10. Blakemore WF. 2008. Regeneration and repair in multiple sclerosis: The view of experimental pathology. J Neurol Sci 265(1-2):1-4.
11. Bogler O, Wren D, Barnett SC, Land H, Noble M. 1990. Cooperation between two growth factors promotes extended self-renewal and inhibits differentiation of oligodendrocyte-type-2 astrocyte (O-2A) progenitor cells. Proc Natl Acad Sci USA 87:6368-6372.
12. Canoll PD, Musacchio JM, Hardy R, Reynolds R, Marchionni MA, Salzer JL. 1996. GGF/neuregulin is a neuronal signal that promotes the proliferation and survival and inhibits the differentiation of oligodendrocyte progenitors. Neuron 17:229-243.
13. Chudakova DA, Zeidan YH, Wheeler BW, Yu J, Novgorodov SA, Kindy MS, Hannun YA, Gudz TI. 2008. Integrin-associated Lyn kinase promotes cell survival by suppressing acid sphingomyelinase activity. J Biol Chem 283:28806-28816.
14. Cohen GM. 1997. Caspases: The executioners of apoptosis. Biochem J 326 (Part 1):1-16.
15. Colognato H, Baron W, Avellana-Adalid V, Relvas JB, Baron-Van Evercooren A, Georges-Labouesse E, ffrench-Constant C. 2002. CNS integrins switch growth factor signalling to promote target-dependent survival. Nat Cell Biol 4:833-841.
16. Colognato H, Ramachandrappa S, Olsen IM, ffrench-Constant C. 2004. Integrins direct Src family kinases to regulate distinct phases of oli-godendrocyte development. J Cell Biol 167:365-375.
17. Compston A, Coles A. 2002. Multiple sclerosis. Lancet 359:1221-1231.
18. Contri A, Brunati AM, Trentin L, Cabrelle A, Miorin M, Cesaro L, Pinna LA, Zambello R, Semenzato G, Donella-Deana A. 2005. Chronic lymphocytic leukemia B cells contain anomalous Lyn tyrosine kinase, a putative contribution to defective apoptosis. J Clin Invest 115:369-378.
19. Decker L, Baron W, Ffrench-Constant C. 2004. Lipid rafts: Microenvironments for integrin-growth factor interactions in neural development. Biochem Soc Trans 32 (Part 3):426-430.
20. Decker L, ffrench-Constant C. 2004. Lipid rafts and integrin activation regulate oligodendrocyte survival. J Neurosci 24:3816-3825.
21. Franklin RJ, Ffrench-Constant C. 2008. Remyelination in the CNS: From biology to therapy. Nat Rev Neurosci 9:839-855.
22. Golubovskaya VM, Gross S, Kaur AS, Wilson RI, Xu LH, Yang XH, Cance WG. 2003. Simultaneous inhibition of focal adhesion kinase and SRC enhances detachment and apoptosis in colon cancer cell lines. Mol Cancer Res 1:755-764.
23. Griffiths GJ, Koh MY, Brunton VG, Cawthorne C, Reeves NA, Greaves M, Tilby MJ, Pearson DG, Ottley CJ, Workman P, et al. 2004. Expression of kinase-defective mutants of c-Src in human metastatic colon cancer cells decreases Bcl-xL and increases oxaliplatinand Fas-induced apoptosis. J Biol Chem 279:46113-46121.
24. Grishin AV, Azhipa O, Semenov I, Corey SJ. 2001. Interaction between growth arrest-DNA damage protein 34 and Src kinase Lyn negatively regulates genotoxic apoptosis. Proc Natl Acad Sci USA 98:10172-10177.
25. Gu J, Nada S, Okada M, Sekiguchi K. 2003. Csk regulates integrinmediated signals: Involvement of differential activation of ERK, Akt. Biochem Biophys Res Commun 303:973-977.
26. Heldin CH, Westermark B. 1999. Mechanism of action and in vivo role of platelet-derived growth factor. Physiol Rev 79:1283-1316.
27. Howe CL, Bieber AJ, Warrington AE, Pease LR, Rodriguez M. 2004. Antiapoptotic signaling by a remyelination-promoting human antimyelin antibody. Neurobiol Dis 15:120-131.
28. Kabuyama Y, Homma MK, Kurosaki T, Homma Y. 2002. Early signaling events induced by 280-nm UV irradiation. Eur J Biochem 269:664-670.
29. Lazebnik YA, Kaufmann SH, Desnoyers S, Poirier GG, Earnshaw WC. 1994. Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE. Nature 371:346-347.
30. Lisak RP, Benjamins JA, Bealmear B, Yao B, Land S, Nedelkoska L, Skundric D. 2006. Differential effects of Th1, monocyte/macrophage and Th2 cytokine mixtures on early gene expression for immunerelated molecules by central nervous system mixed glial cell cultures. Mult Scler 12:149-168.
31. McCarthy KD, de Vellis J. 1980. Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue. J Cell Biol 85:890-902
32. Miller DJ, Sanborn KS, Katzmann JA, Rodriguez M. 1994. Monoclonal autoantibodies promote central nervous system repair in an animal model of multiple sclerosis. J Neurosci 14:6230-6238.
33. Milner R, Ffrench-Constant C. 1994. A developmental analysis of oligodendroglial integrins in primary cells: Changes in alpha v-associated beta subunits during differentiation. Development 120:3497-3506.
34. Milner R, Frost E, Nishimura S, Delcommenne M, Streuli C, Pytela R, Ffrench-Constant C. 1997. Expression of alpha vbeta3 and alpha vbeta8 integrins during oligodendrocyte precursor differentiation in the presence and absence of axons. Glia 21:350-360.
35. Mronga T, Stahnke T, Goldbaum O, Richter-Landsberg C. 2004. Mitochondrial pathway is involved in hydrogen-peroxide-induced apoptotic cell death of oligodendrocytes. Glia 46:446-455.
36. Nicholson DW, Ali A, Thornberry NA, Vaillancourt JP, Ding CK, Gallant M, Gareau Y, Griffin PR, Labelle M, Lazebnik YA, et al. 1995. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 376:37-43.
37. Noseworthy JH, Lucchinetti C, Rodriguez M, Weinshenker BG. 2000. Multiple sclerosis. N Engl J Med 343:938-952.
38. Park SS, Eom YW, Kim EH, Lee JH, Min DS, Kim S, Kim SJ, Choi KS. 2004. Involvement of c-Src kinase in the regulation of TGF-beta1induced apoptosis. Oncogene 23:6272-6281.
39. Pavelko KD, van Engelen BG, Rodriguez M. 1998. Acceleration in the rate of CNS remyelination in lysolecithin-induced demyelination. J Neurosci 18:2498-2505.
40. Robinson S, Tani M, Strieter RM, Ransohoff RM, Miller RH. 1998. The chemokine growth-regulated oncogene-alpha promotes spinal cord oligodendrocyte precursor proliferation. J Neurosci 18:10457-10463.
41. Sharma DK, Brown JC, Cheng Z, Holicky EL, Marks DL, Pagano RE. 2005. The glycosphingolipid, lactosylceramide, regulates beta1-integrin clustering and endocytosis. Cancer Res 65:8233-8241.
42. Tewari M, Quan LT, O'Rourke K, Desnoyers S, Zeng Z, Beidler DR, Poirier GG, Salvesen GS, Dixit VM. 1995. Yama/CPP32 beta, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase. Cell 81:801-809.
43. Warrington AE, Asakura K, Bieber AJ, Ciric B, Van Keulen V, Kaveri SV, Kyle RA, Pease LR, Rodriguez M. 2000. Human monoclonal antibodies reactive to oligodendrocytes promote remyelination in a model of multiple sclerosis. Proc Natl Acad Sci USA 97:6820-6825.
44. Warrington AE, Bieber AJ, Ciric B, Pease LR, Van Keulen V, Rodriguez M. 2007. A recombinant human IgM promotes myelin repair after a single, very low dose. J Neurosci Res 85:967-976.
45. Warrington AE, Rodriguez M. 2008. Remyelination-promoting human IgMs: Developing a therapeutic reagent for demyelinating disease. Curr Top Microbiol Immunol 318:213-239.